Arkley BioTek, LLC
IndyWeb Site
Indianapolis, United States · Founded 2015 · $1.6M raised
- Headquarters
- Indianapolis, Indiana
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2G
- Website
- arkleybiotek.com
- Total Funding
- $1.6M
About
Arkley BioTek is developing blood-based diagnostics for the early detection of Alzheimer's disease. The company is leveraging redox-reactive autoantibodies (R-RAA) as an early, non-invasive serum biomarker for Alzheimer's disease in patients suffering from Mild Cognitive Impairment, enabling detection before significant neurodegeneration occurs.
Summary
Arkley BioTek, LLC is a Biotech company based in Indianapolis, United States, founded in 2015. It has raised $1.6M in total.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...